Head and Neck Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
Conditions: Recurrent Head and Neck Cancer; Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma; Metastatic Head and Neck Cancer; HNSCC Interventions: Drug: Ramucirumab; Drug: Pembrolizumab Sponsors: Washington University School of Medicine; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: IO102-103 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; IO Biotech; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
Conditions: Recurrent Head and Neck Cancer; Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma; Metastatic Head and Neck Cancer; HNSCC Interventions: Drug: Ramucirumab; Drug: Pembrolizumab Sponsors: Washington University School of Medicine; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: IO102-103 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; IO Biotech; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
Conditions: Recurrent Head and Neck Cancer; Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma; Metastatic Head and Neck Cancer; HNSCC Interventions: Drug: Ramucirumab; Drug: Pembrolizumab Sponsors: Washington University School of Medicine; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: IO102-103 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; IO Biotech; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
Conditions: Recurrent Head and Neck Cancer; Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma; Metastatic Head and Neck Cancer; HNSCC Interventions: Drug: Ramucirumab; Drug: Pembrolizumab Sponsors: Washington University School of Medicine; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Conditions: Breast Cancer; Oral Cancer Intervention: Drug: Cannabis capsules Sponsor: Tata Memorial Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Head and Neck Cancer
Conditions: Head and Neck Cancer; Metabolite Intervention: Diagnostic Test: Proteomics technology and liquid biopsy Sponsor: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Conditions: Breast Cancer; Oral Cancer Intervention: Drug: Cannabis capsules Sponsor: Tata Memorial Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Head and Neck Cancer
Conditions: Head and Neck Cancer; Metabolite Intervention: Diagnostic Test: Proteomics technology and liquid biopsy Sponsor: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Conditions: Breast Cancer; Oral Cancer Intervention: Drug: Cannabis capsules Sponsor: Tata Memorial Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Head and Neck Cancer
Conditions: Head and Neck Cancer; Metabolite Intervention: Diagnostic Test: Proteomics technology and liquid biopsy Sponsor: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials